111 related articles for article (PubMed ID: 2568798)
1. Pharmacokinetics of iotrolan after intravenous injection into healthy volunteers.
Scholz P; Weinmann HJ; Mützel W; Staks T
Fortschr Geb Rontgenstrahlen Nuklearmed Erganzungsbd; 1989; 128():211-4. PubMed ID: 2568798
[TBL] [Abstract][Full Text] [Related]
2. Tissue distribution and excretion of iotrolan after intravenous and suboccipital injections in animals.
Weinmann HJ; Scholz P; Mützel W
Fortschr Geb Rontgenstrahlen Nuklearmed Erganzungsbd; 1989; 128():206-10. PubMed ID: 2568796
[TBL] [Abstract][Full Text] [Related]
3. Experimental urography in dogs: diagnostic quality and pharmacokinetic behavior of iotrolan in comparison to nonionic and ionic, monomeric contrast media.
Nauert C; Mützel W
Fortschr Geb Rontgenstrahlen Nuklearmed Erganzungsbd; 1989; 128():82-7. PubMed ID: 2568814
[TBL] [Abstract][Full Text] [Related]
4. Plasma level and renal excretion of iotrolan after lumbar injection in patients.
Weinmann HJ; Vogelsang H; Mützel W; Speck U
Fortschr Geb Rontgenstrahlen Nuklearmed Erganzungsbd; 1989; 128():224-7. PubMed ID: 2568801
[TBL] [Abstract][Full Text] [Related]
5. Urography with monomeric and dimeric nonionic contrast media: comparative, randomized, double-blind study of iotrolan 280 and iopromide 300.
Taenzer V; Wenzel-Hora BI
Fortschr Geb Rontgenstrahlen Nuklearmed Erganzungsbd; 1989; 128():116-8. PubMed ID: 2568778
[TBL] [Abstract][Full Text] [Related]
6. Pharmacokinetics of iopromide in rat and dog.
Mützel W; Speck U; Weinmann HJ
Fortschr Geb Rontgenstrahlen Nuklearmed Erganzungsbd; 1983; 118():85-90. PubMed ID: 6139085
[No Abstract] [Full Text] [Related]
7. Pharmacokinetics of iohexol, iopamidol, iopromide, and iosimide compared with meglumine diatrizoate.
Hartwig P; Mützel W; Taenzer V
Fortschr Geb Rontgenstrahlen Nuklearmed Erganzungsbd; 1989; 128():220-3. PubMed ID: 2568800
[TBL] [Abstract][Full Text] [Related]
8. Organ-specific and general tolerance of iotrolan 280 after intravenous administration: phase I study in healthy volunteers.
Staks T; Seifert W; Wenzel-Hora BI; Fuhrmeister A
Fortschr Geb Rontgenstrahlen Nuklearmed Erganzungsbd; 1989; 128():33-8. PubMed ID: 2568805
[TBL] [Abstract][Full Text] [Related]
9. Renal excretion and computed tomography enhancement of iotrolan and iopamidol in dogs.
Benness G; Evill C; Wilcox J; Hassam R; Arozoo E
Fortschr Geb Rontgenstrahlen Nuklearmed Erganzungsbd; 1989; 128():88-90. PubMed ID: 2568815
[TBL] [Abstract][Full Text] [Related]
10. Human pharmacokinetics of iodixanol.
Svaland MG; Haider T; Langseth-Manrique K; Andrew E; Hals PA
Invest Radiol; 1992 Feb; 27(2):130-3. PubMed ID: 1601604
[TBL] [Abstract][Full Text] [Related]
11. Physicochemical properties and general pharmacology of the nonionic dimer iotrolan.
Mützel W; Press WR; Weinmann HJ
Fortschr Geb Rontgenstrahlen Nuklearmed Erganzungsbd; 1989; 128():28-32. PubMed ID: 2568804
[TBL] [Abstract][Full Text] [Related]
12. [Non-ionic iodinated dimeric versus monomeric X-ray contrast media: effects on complement factors in vivo].
Böhm I; Speck U; Schild H
Rofo; 2006 Mar; 178(3):306-12. PubMed ID: 16508838
[TBL] [Abstract][Full Text] [Related]
13. Pharmacokinetics of iopentol in patients with chronic renal failure.
Svaland MG; Kolmannskog F; Lillevold PE; Nordal KP; Ressem L; Berg KJ
Acta Radiol; 1992 Sep; 33(5):482-4. PubMed ID: 1389660
[TBL] [Abstract][Full Text] [Related]
14. Initial experience with a nonionic, dimeric contrast medium (iotrolan) in direct and indirect arteriography: a randomized, intraindividual double-blind study in 60 patients.
Hagen B; Wenzel-Hora BI
Fortschr Geb Rontgenstrahlen Nuklearmed Erganzungsbd; 1989; 128():54-60. PubMed ID: 2568808
[TBL] [Abstract][Full Text] [Related]
15. Renal effects of the non-ionic contrast medium iopentol after intravenous injection in healthy volunteers.
Jakobsen JA; Berg KJ; Waaler A; Andrew E
Acta Radiol; 1990 Jan; 31(1):87-91. PubMed ID: 2187515
[TBL] [Abstract][Full Text] [Related]
16. Tolerance to iotrolan after subarachnoid injection in animals.
Press WR; Mützel W; Schöbel C
Fortschr Geb Rontgenstrahlen Nuklearmed Erganzungsbd; 1989; 128():126-33. PubMed ID: 2568780
[TBL] [Abstract][Full Text] [Related]
17. [Experimental study on vascular permeability and hemodynamics of nonionic dimeric contrast media (Iotrolan): a comparison to nonionic monomer on dynamic CT and angiography].
Sako M; Sugimoto K; Hirota S; Matsumoto S; Kuwata Y; Hasegawa Y; Tomita M; Murakami T; Kono M
Nihon Igaku Hoshasen Gakkai Zasshi; 1994 Jan; 54(1):32-9. PubMed ID: 8121768
[TBL] [Abstract][Full Text] [Related]
18. Arthrography with iotrolan: double-blind comparison between nonionic, monomeric (iohexol 300) and nonionic, dimeric (iotrolan 300) contrast media.
Schmidt M; Papassotiriou V
Fortschr Geb Rontgenstrahlen Nuklearmed Erganzungsbd; 1989; 128():182-9. PubMed ID: 2568791
[TBL] [Abstract][Full Text] [Related]
19. Pharmacokinetics of iopentol in healthy volunteers.
Waaler A; Jørgensen NP; Koksvik B; Skinnemoen K; Andrew E
Acta Radiol Suppl; 1987; 370():113-7. PubMed ID: 2980304
[TBL] [Abstract][Full Text] [Related]
20. Pharmacokinetics of iohexol, a new nonionic radiocontrast agent, in humans.
Edelson J; Shaw D; Palace G
J Pharm Sci; 1984 Jul; 73(7):993-5. PubMed ID: 6470969
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
